Comparative Analysis of Orthokeratology Lenses and Low-Concentration Atropine Eye Drops on Axial Length Elongation
Author:
Open Access
- 25 March 2025
- journal article
- Published by The Korean Optometry Society and The Korean Contact Lens Study Society in Annals of Optometry and Contact Lens
- Vol. 24 (1) , 27-33
Abstract
Purpose: To compare the effects on axial elongation and associated factors between orthokeratology lenses and 0.025% low-concentration atropine eye drops.Methods: A retrospective analysis was conducted on the medical records of children matched by sex and age, with a spherical equivalent difference within 0.125 diopters, who were followed for more than 2 years after starting treatment with orthokeratology lenses or 0.025% low-concentration atropine eye drops. The results of refractive error and axial length were analyzed using an independent t-test, paired t-test, Pearson correlation test, and multiple regression analysis.Results: Seventy-four patients (92 eyes) were included in this study. Before treatment, the axial length was 24.44 ± 0.91 mm in the orthokeratology lenses group and 24.67 ± 0.80 mm in the low-concentration atropine eye drops group. There were no statistically significant differences between the two groups in age at the start of treatment, sex, spherical equivalent, and axial length before treatment. At the 2-year follow-up, the mean axial length change was 0.53 ± 0.30 mm in the orthokeratology lenses group and 0.49 ± 0.26 mm in the low-concentration atropine eye drops group, respectively. There were no statistically significant differences between the two groups in the mean axial length change. Additionally, the age at the start of treatment showed a significant negative correlation with the axial length change in both the orthokeratology lenses group and the low-concentration atropine eye drops group (p = 0.001, p = 0.011, respectively).Conclusions: There was no significant difference in axial elongation for 2 years between orthokeratology lenses and 0.025% low-concentration atropine eye drops treatment groups. Since younger age was associated with faster eye growth, it is important to actively consider treatment in cases of early onset myopia.Keywords
This publication has 18 references indexed in Scilit:
- Comparison of the clinical efficacy of orthokeratology and 0.01% atropine for retardation of myopia progression in myopic childrenContact Lens and Anterior Eye, 2023
- Long-Term Efficacy of Orthokeratology to Control Myopia ProgressionEye & Contact Lens: Science & Clinical Practice, 2023
- Topical Review: Studies on Management of Myopia Progression from 2019 to 2021Optometry and Vision Science, 2023
- Factors Related to Axial Length Elongation in Myopic Children Who Received 0.05% Atropine TreatmentJournal of Ocular Pharmacology and Therapeutics, 2022
- The Risks and Benefits of Myopia ControlOphthalmology, 2021
- Low-Concentration Atropine Eye Drops for Myopia ProgressionAsia-Pacific Journal of Ophthalmology, 2019
- Myopia Progression Rates in Urban Children Wearing Single‐Vision SpectaclesOptometry and Vision Science, 2012
- Interventions to slow progression of myopia in childrenCochrane Database of Systematic Reviews, 2011
- The Long-Term Results of Using Low-Concentration Atropine Eye Drops for Controlling Myopia Progression in SchoolchildrenJournal of Ocular Pharmacology and Therapeutics, 2011
- Relationship of Age, Sex, and Ethnicity With Myopia Progression and Axial Elongation in the Correction of Myopia Evaluation TrialArchives of Ophthalmology (1950), 2005